3PC-038 Ifosfamide-induced encephalopathy: quality control of intravenous solution of methylene blue formulated and prepared in pharmacy using a disposable closed system transfer device – a case report

BACKGROUND: Encephalopathy is a rare but serious central nervous system toxicity of ifosfamide. Its clinical symptoms are confusion, stupor, seizures, hallucinations and blurred vision.(1) The methylene blue (MB) is administered as an antidote to the encephalopathy. PURPOSE: Description of MB formul...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Benabbes, M, Chentoufi, M Alami, Lakhdissi, A, Abahssain, H, Errihani, H, Meddah, B
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 3: Production and compounding
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535579/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.90
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia